Institution identification

PURI

https://redirect.ema.europa.eu/resource/20882

Institution ID

20882

Institution full name and acronym

Fundación Centro Español de Investigación Farmacoepidemiológica (CEIFE)

Institution countries

Spain

Type of institution

Not-for-profit

Institution website

ENCePP partner

Yes
Institution description
The Centro Español de Investigación Farmacoepidemiológica-CEIFE (Spanish Centre for Pharmacoepidemiologic Research) is a research unit created in 1994 in Madrid. Its mission is to provide high quality research on drug safety and effectiveness,by means of epidemiologic studies utilizing computerized databases. Four main sources of information are used: General Practice Research Database and The Health Improvement Network,both in the UK,BIFAP Database in Madrid and Saskatchewan Database in Canada. CEIFE collaborates with industry,regulatory authorities and Other universities at a national and international level. Permanent staff includes four epidemiologists and one information systems analyst. Postgraduate students and Other research collaborators spend varying periods of time on a project-specific basis.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact

Studies conducted by the institution

A cohort study on the association between acid-suppressing drugs in pregnancy and asthma in the offspring (Acid-suppressing Drugs Pregnancy Asthma Offspring)
A cohort study with a nested case control analysis on the association between acid-suppressing drugs and seizures using THIN database in the UK (Acid suppressing Drug Seizure Epidemiology Study)
A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in the United Kingdom
A pharmacoepidemiological study on the risk of bleeding in new users of low-dose aspirin (ASA) in The Health Improvement Network (THIN), UK (EPISAT)
Adverse ReNal OuTcomEs in patients with NoN-Valvular Atrial fibrillation treated with Rivaroxaban or Vitamin K Antagonists (ANTENNA)
Cohort Study of the Relative Incidence of Major Cardiovascular Events Among Patients Initiating Prucalopride Versus a Matched Comparator Cohort
Drug utilization study of cyproterone/ethinylestradiol (Diane®-35 and generics) in the Netherlands, UK and Italy
Pattern of use of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation patients in UK general practices
Safety and Effectiveness of Rivaroxaban and Apixaban compared to warfarin in non-valvular atrial fibrillation patients in the routine clinical practice in the UK (SiERRA UK)
The risk of acute liver injury associated with the use of antibiotics. A methodological comparison across epidemiological data sources
Treatment Pattern of NOACs (non-vitamin K oral anticoagulants) in Outpatient Users in Colombian Databases - TREND Colombia